CSL stock rises as healthcare leads the ASX 200

Published on 09/20/2026 at 20:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CSL Ltd stock rose 5.08 percent to AUD 175.59 last week as the ASX 200 health care index gained 3.76 percent. The broader ASX 200 slipped 0.11 percent.

CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL Ltd stock (ISIN AU000000CSL8) rose 5.08 percent to AUD 175.59 last week, while the S&P/ASX 200 Health Care Index gained 3.76 percent and the broader S&P/ASX 200 Index slipped 0.11 percent on Friday.

Healthcare outperforms

According to Fool Australia, CSL was one of the sector leaders as healthcare shares advanced 3.76 percent over five trading days, far ahead of the 0.11 percent weekly decline in the S&P/ASX 200.

The same report says CSL shares are up 90 percent since June 3, 2026, a move that puts the stock's recent run well ahead of the broader market's weekly tone.

What the market is pricing

The market backdrop is being shaped by an 82 percent chance of another 0.25 percent rate hike at the end of the month, according to Fool Australia. For CSL, that leaves the current debate centered on healthcare resilience rather than on the wider index direction.

CSL traded at AUD 175.59 as of September 19, 2026, after a 5.08 percent weekly rise, with the shares up 90 percent since June 3, 2026.

Stock near the latest level

CSL stock closed at AUD 175.59 on September 19, 2026, giving investors a current reference point in the same currency as the ASX listing. The next leg is likely to be judged against the recent 90 percent advance since June 3, 2026.